Psoriasis Clinical Trials

Showing 201-220 of 478 trials

Impact of Secukinumab on Clinical and Patient Reported Outcomes in Patients With Psoriasis

NCT05513014

The study was conducted to describe the demographics, disease characteristics, disease severity, comorbidities and patient reported outcomes at baseline and follow-up periods among adult patients diagnosed with PsO in CorEvitas' PsO Registry under routine medical care initiating secukinumab (SEC).

Psoriasis

Novartis Pharmaceuticals1,518 participantsStarted Mar 2021

East Hanover, New Jersey, United States

COMPLETEDPHASE3

A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

NCT03219437

The purpose of this study is to compare the safety and efficacy of risankizumab to methotrexate in participants with moderate to severe plaque psoriasis.

Psoriasis

AbbVie104 participantsStarted Jul 2018

Curitiba, Paraná, Brazil • Curitiba, Paraná, Brazil • Porto Alegre, Rio Grande do Sul, Brazil +8 more locations

Impact of Secukinumab on Clinical and Patient Reported Outcomes in Patients With Psoriasis

A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

Related Searches

Neuropathic Pain in Psoriatic Arthritis

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis

Proton Pump Inhibitors Use in Patients With Psoriasis

Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral

The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis

Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis

Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

Survey About Diet in Chronic Inflammatory Rheumatic Diseases

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)

An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis.

Genetic Analysis of Pediatric Psoriasis

Spanish Registry of Systemic Treatments in Psoriasis

Bioequivalence Phase I Study of BFI-751 Compared With EU and US-STELARA® in Healthy Adults